Дункан Кармайкл - Молодость навсегда. Как замедлить процессы старения и сохранить здоровье
- Название:Молодость навсегда. Как замедлить процессы старения и сохранить здоровье
- Автор:
- Жанр:
- Издательство:неизвестно
- Год:2018
- ISBN:978-5-389-18963-8
- Рейтинг:
- Избранное:Добавить в избранное
-
Отзывы:
-
Ваша оценка:
Дункан Кармайкл - Молодость навсегда. Как замедлить процессы старения и сохранить здоровье краткое содержание
«Современный мир дает возможность как поддерживать здоровье в пре-красном состоянии, так и еще в молодом возрасте „заработать“ тяжелые хронические заболевания. Очевидно, что в большинстве случаев наше здоровье в наших руках. Вопрос в том, как определить, что помогает, а что вредит? Все так быстро меняется во всех областях медицины, что вчерашнее лекарство завтра может быть признано вредным (и это не учитывая аферистов в белых халатах, пытающихся впарить шарлатанские средства от всех болезней). Поиск надежной информации в эпоху интернета становится нелегкой задачей. Моя цель – составить для вас полезную дорожную карту». (Дункан Кармайкл)
В формате PDF A4 сохранён издательский дизайн.
Молодость навсегда. Как замедлить процессы старения и сохранить здоровье - читать онлайн бесплатно ознакомительный отрывок
Интервал:
Закладка:
113
Keys, A. ‘Coronary Heart Disease in Seven Countries.’ Circulation (1970): 41 (4S 1): 1–198.
114
‘The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.’ JAMA (1984): 251: 351–364.
115
Endo, A. ‘A Historical Perspective on the Discovery of Statins.’ Proc Jpn Acad Ser B Phys Biol Sci (2010): 86: 484–493.
116
Strandberg, T. et al. ‘Cholesterol Lowering after Participation in the Scandinavian Simvastatin Survival Study 4S.’ European Heart Journal (1997): 18: 11: 1725–1727.
117
См. например: https://www.cdc.gov/diabetes/statistics/slides/maps_diabetesobesity_trends.pdf.
118
Yerushalmy, Y. and Hilleboe, H. E. ‘Fat in the Diet and Mortality from Heart Disease: A Methodologic Note.’ NY State J Med (1957): 57: 2343–2354.
119
Ridker, P. M. ‘C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction.’ Circulation (1998): 97: 20: 2007–2011.
120
Fonseca, F. A. H. et al. ’High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities.’ Clinics (2016): 71: 235–242.
121
Tonkin, A. M. et al. ‘Effects of Pravastatin on 3,260 Patients with Unstable Angina: Results from the LIPID Study.’ The Lancet (2000).
122
De Rao, A. ‘To JUPITER and Beyond: Statins, Inflammation and Primary Prevention.’ Critical Care (2010) 14: 310.
123
Ibid.
124
Hippisley-Cox, J., Coupland, C. ‘Unintended Effects of Statins in Men and Women in England and Wales: Population-based Cohort Study Using the QResearch database.’ BMJ (2010): 340: c2197.
125
Pignone, M. et al. ‘Aspirin, Statins or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost-utility Analysis.’ Ann Intern Med(2006): Vol 144, 5: 326–336.
126
Tavazzi, L. ‘Rationale and Design of the GISSI Heart Failure Trial: A Large Trial to Assess the Effects of N-3 Polyunsaturated Fatty Acids and Rosuvastatin in Symptomatic Congestive Heart Failure.’ Eur J of Heart Fail (2004): 6: 635–641.
127
Harding, S. V. et al. ‘Evidence for Using Alpha-lipoic Acid in Reducing Lipoprotein and Inflammatory-related Atherosclerotic Risk.’ J Diet Suppl (2012): 9: 116–127.
128
Apostolov, E. O. ‘Carbamylated-oxidized LDL: Proatherosclerotic Effects on Endothelial Cells and Macrophages.’ J Atheroscler Thromb (2013): 20: 878–892.
129
Ogawa, K. et al. ‘Increase in the Oxidised Low-density Lipoprotein Level by Smoking, and the Possible Inhibitory Effect of Statin Therapy in Patients with Cardiovascular Disease: A Retrospective Study.’ BMJ Open (2016). URL:: http://bmjopen.bmj.com/content/5/1/e005455.
130
Jacobs, L. et al. ‘Traffic Air Pollution and Oxidised LDL.’ PLoS One (2011): 6. URL: ised LDL.’ PLoS One (2011): 6. URL: https://www.ncbi.nlm.nih.gov/pubmed/21283820.
131
Boushehri, S. N. et al. ‘Effect of Vitamin Supplementation on Serum-Oxidized Low-Density Lipoprotein Levels in Male Subjects with Cardiovascular Disease Risk Factors.’ Iran J Basic Med Sci (2012, July – August): 15 (4): 958–964.
132
Wang, Y. et al. ‘Molecular Mechanism of Glutathione-mediated Protection from Oxidised Low-density Lipoprotein Protein-induced Cell Injury in Human Macrophages: Role of Glutathione Reductase and Glutaredoxin.’ Free Radic Biol Med (2006): 41: 775–785.
133
‘Novartis Phase III CANTOS Study Demonstrates that Targeting Inflammation ACZ885 Reduces Cardiovascular Risk’ (27 August 2017). URL: https://www.novartis.com/news/media-releases/novartis-phase-iii-cantos-study-demonstrates-targeting-inflammation-acz885.
134
Levine, M. et al. ‘Low Protein Intake is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population.’ Cell Metabolism (2014): 19: 407–417.
135
Bray, G. et al. ‘Dietary Sugar and Body Weight: Have We Reached a Crisis in the Epidemic of Obesity and Diabetes? Health be damned! Pour on the sugar.’ Diabetes Care (2014): 37: 950–956.
136
‘Just How Much Sugar Do Americans Consume? It’s complicated.’ Associated Press (20 September 2016).
137
См. рекомендации Американской ассоциации кардиологов: http://www.heart.org/HEARTORG/HealthyLiving/HealthyEating/Nutrition/Added-Sugars_UCM_305858_Article.jsp#.WbIi9q2Q1sM.
138
Wang, Y. ‘The Obesity Epidemic in the United States – Gender, Age, Socioeconomic, Racial/Ethnic, and Geographic Characteristics: A Systematic Review and Meta-Regression Analysis.’ Am J Epidemiol (2007): 29: 6–28.
139
Streib, L. ‘World’s Fattest Countries.’ Forbes (8 February 2007).
140
‘Future Diets: The Global Rise of Obesity’. ODI (2014). URL: https://www.odi.org/opinion/9329-future-diets-global-rise-obesity.
141
French, S. A. et al. ‘Fast-food Restaurant-use Among Women in the Pound of Prevention Study: Dietary, Behavioral and Demographic Correlates.’ Nature (2000): 24: 1353–1359.
142
Ahmed, S. H. et al. ‘Intense Sweetness Surpasses Cocaine Reward.’ PLoS One (2007).
143
Hoebel, B, et al. ‘Sugar and Fat-bingeing Have Notable Dif erences in Addictive-like Behaviour.’ J Nutr (2009): 139: 623–628.
144
Corwin, R. L. et al. ‘Limited Access to a Dietary Fat Option Af ects Ingestive Behavior But Not Body Composition in Male Rats.’ Physiol Behav (1998): 65: 545–553.
145
Hoebel, B, et al. ‘Sugar and Fat-bingeing Have Notable Dif erences in Addictive-like Behaviour’. J Nutr (2009): 139: 623–628.
146
Kearns, C. E. et al. ‘Sugar Industry and Coronary Heart Disease Research: A Historical Analysis of Internal Industry Documents.’ JAMA (2016): 176: 1680–1685.
147
O’Connor, A. ‘How the Sugar Industry Shifted Blame to Fat.’ The New York Times (12 September 2016).
148
Kearns, C. E. et al. ‘Sugar Industry and Coronary Heart Disease Research: A Historical Analysis of Internal Industry Documents.’ JAMA (2016): 176: 1680–1685.
149
O’Connor, A. ‘Study Tied to Food Industry Tries to Discredit Sugar Guidelines.’ The New York Time (19 December 2016).
150
O’Connor, A. ‘Sugar Industry Long Downplayed Potential Harms.’ The New York Times (21 November 2017).
151
‘Independent experts find no grounds for retraction of BMJ article on dietary guidelines.’ The BMJ (2 December 2016). См. заявление BMJ для прессы: http://www.bmj.com/company/wp-content/uploads/2016/12/the-bmj-US-dietary-correction.pdf.
152
Teicholz, N. The Big Fat Surprise: Why Butter, Meat and Cheese Belong in a Healthy Diet. Simon & Schuster (2014).
153
Dietary guidelines for Americans, 2015–2020. Eighth Edition: https://health.gov/dietaryguidelines/2015/guidelines/.
154
‘Fewer Get Heart Attacks.’ Socialstyrelsen (4 November 2013). URL: http://www.socialstyrelsen.se/nyheter/2013november/farrefarhjartinfarkt.
155
Asmat et al. ‘Diabetes mellitus and oxidative stress – a concise review.’ Saudi Pharm J (2016): 24: 547–553.
156
Fields, S. ‘The Fat of the Land: Do Agricultural Subsidies Foster Poor Health?’ Environ Health Perspect (2004): 112: A820–823.
157
Lopes, M. and Prentice, C. ‘U.S. Corn Syrupmakers Slash Prices to Fend Of Cheap Sugar.’ Reuters (11 November 2013).
158
Younossi, Z. M. et al. ‘Global Epidemiology of Non-Alcoholic Fatty Liver Disease – Meta-Analytic Assessment of Prevalence, Incidence and Outcomes.’ Hepatology (2016): 64: 73–84.
159
Browning, J. D. et al. ‘Prevalence of Hepatic Steatosis in an Urban Population in the United States: Impact of Ethnicity.’ Hepatology (2004): 40 (6): 1387–1395.
160
Samuel, V. T. ‘Fructose-induced Lipogenesis: From Sugar to Fat to Insulin Resistance.’ Trends Endocrinol Metab (2011): 22: 60–65.
161
Lustig, R. Fat Chance: The Hidden Truth About Sugar, Obesity and Disease. Harper Collins (2012).
162
Stout, R. W. ‘Insulin-stimulated Lipogenesis in Arterial Tissue in Relation to Diabetes and Atheroma.’ The Lancet (1968): 2: 7570: 702–703.
163
Steinberg, D. ‘Thematic Review Series: The Pathogenesis of Atherosclerosis. An Interpretive History of the Cholesterol Controversy: Part 11: The Early Evidence Linking Hypercholesterolemia to Coronary Disease in Humans.’ J Lipid Res (2005): 46: 2: 179–190.
164
Mohanty, P. et al. ‘Glucose Challenge Stimulates Reactive Oxygen Species (ROS) Generation by Leucocytes.’ J Clin Endocrinol Metab (2000): 85 (8): 2970–2973.
165
Torres-Leal, F. L. et al. ‘The Role of Infl amed Adipose Tissue in Insulin Resistance.’ Cell Biochem Funct (December 2010): Vol 28: 623–631.
166
Chen, L. et al. ‘Mechanisms Linking Infl ammation to Insulin Resistance.’ Int J Endocrinol (2015): 508409: https://www.hindawi.com/journals/ije/2015/508409/.
167
Semenkovich, C. F. ‘Insulin Resistance and Atherosclerosis.’ J Clin Invest (2006): 116: 1813–1822.
168
Ibid.
169
Acheson, K. J. et al. ‘Metabolic Effects of Caf eine in Humans: Lipid Oxidation or Futile Cycling.’ Am J Clin Nutr (2004): 79: 40–46.
170
Duan, W. ‘Dietary Restriction Normalizes Glucose Metabolism and Brain-Derived Neurotrophic Factor Levels, Slows Disease Progression and Increases Survival in Huntington Mutant Mice.’ Proc Natl Acad Sci USA (4 March 2003): 100: 2911–2916.
171
Cassidy, S. et al. ‘High-intensity Interval Training: A Review of its Impact on Glucose Control and Cardiometabolic Health.’ Diabetologia (2017): 60: 7–23.
172
Lee, C. ‘Dietary Restriction with and without Caloric Restriction for Healthy Aging.’ Faculty Review (2016). URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755412/.
173
Mengmeng, L. V. et al. ‘Roles of Caloric Restriction, Ketogenic Diet and Intermittent Fasting during Initiation, Progression and Metastasis of Cancer in Animal Models: A Systematic Review and Meta-Analysis.’ PLoS One (2014): 9 (12): e115147.
Читать дальшеИнтервал:
Закладка:
